Mushroom Supplement Regulations by Country: How Standards Differ in the US, EU and Asia

How Mushroom Supplement Regulation Differs Around the World

Editorial Notice: This article is for general education. It is not medical, legal, or import advice. Always consult a qualified healthcare provider before starting any supplement, and check current rules with the relevant government agency before importing or selling a product.

The United States treats mushroom supplements as food, not drugs, and lets companies market them without government pre-approval. The European Union requires many mushroom extracts to pass a formal safety review before they can be sold at all. Several Asian countries, including China, Japan, and South Korea, have separate legal categories built specifically for functional and medicinal foods. That means the same lion’s mane capsule can be legal in one country and require extra paperwork, or be outright unauthorized, in another.

The United States: Manufacturer Responsibility, Not Government Pre-Approval

In the US, mushroom supplements fall under the Dietary Supplement Health and Education Act of 1994, known as DSHEA. Under this law, the FDA does not review or approve dietary supplements before they reach store shelves. Instead, the company that makes or distributes the product is responsible for making sure it is safe and honestly labeled before it goes to market.

The FDA’s role happens mostly after the fact. The agency can inspect manufacturing facilities, review labels, and take enforcement action against products that are “adulterated” (unsafe or contaminated) or “misbranded” (mislabeled or making illegal claims). A new ingredient that was not sold in the US before DSHEA took effect generally requires a New Dietary Ingredient notification to the FDA before it can be marketed.

This system means a product can legally reach the market with no independent government safety check. It does not mean the product is unsafe. It means the burden of proof rests with the company, and that labels reading “FDA approved” on a supplement are inaccurate, since dietary supplements are not approved the way drugs are.

The European Union: Species-by-Species Novel Food Review

The EU takes a stricter, more centralized approach. Under the Novel Food Regulation, any food or food ingredient that was not commonly eaten in the EU before May 15, 1997, is classified as a “novel food” and needs formal authorization before it can be sold. Many functional mushroom extracts fall into this category, because the concentrated extracts sold today are different from the whole mushrooms traditionally eaten as food.

The European Food Safety Authority (EFSA) reviews the safety dossier a company submits, and the European Commission makes the final call on whether to add the ingredient to the EU list of authorized novel foods. This process can take years and requires detailed safety data.

The practical result: authorization is granted extract by extract, not mushroom by mushroom. For example, a shiitake mycelial extract was formally authorized as a novel food ingredient by the European Commission in 2011. Meanwhile, Cordyceps militaris extracts are classified as novel and require separate authorization, even though preparations from other cordyceps species may already have a longer history of use. Species that look similar on a supplement label can sit in very different regulatory positions in the EU.

EFSA also suspended its evaluation of health claims for plant and mushroom ingredients in 2010. In practice, this means most mushroom supplements sold in the EU today cannot legally carry an EFSA-authorized health claim on the label, even when a company believes the underlying research supports one.

Asian Markets: Formal Legal Categories for Functional Foods

Several Asian countries have established dedicated legal categories for products such as functional mushrooms, which sit between ordinary food and medicine.

• China regulates these products as “health food” and oversees them through the State Administration for Market Regulation (SAMR). Products get either a faster “filing” if they use an ingredient already on the approved raw material list, or a slower “registration” if they use a new ingredient or make a specific health function claim. Ganoderma lucidum (reishi) spore powder is one of the most commonly filed raw materials in this system.
• Japan has two relevant categories. Foods for Specified Health Uses (FOSHU), created in 1991 by the Ministry of Health, Labor and Welfare, require individual government review of clinical safety and effectiveness data before a specific product can carry a health claim. Foods with Function Claims (FFC), introduced in 2015, allow a company to market a claim based on its own scientific review without full government pre-approval, as long as it notifies the Consumer Affairs Agency first.
• South Korea regulates these products under the Health Functional Food Act of 2002, overseen by the Ministry of Food and Drug Safety (MFDS). Like Japan, Korea has two tiers: one requiring individual functional ingredient recognition, and a notification-based route for products using already-recognized ingredients.

The common thread across China, Japan, and Korea is that all three treat functional mushrooms as their own legal category, with government agencies playing a more active, product-specific role than the FDA’s after-the-fact model in the US.

What the Differences Mean for Shoppers

• United States: No product pre-approval. The company is responsible for safety and label accuracy. The FDA acts mainly through inspections and after-market enforcement.
• European Union: Many extracts need formal novel food authorization before sale. Authorization is extract-specific, not species-wide. Most mushroom products cannot legally carry an authorized health claim.
• China: Products are filed or registered with SAMR depending on the ingredient. Imported products need a “health food” certificate before they can be sold.
• Japan: FOSHU claims require a full government review for each product. FFC claims are company-notified, based on the company’s own evidence review.
• South Korea: Regulated under a dedicated Health Functional Food Act, with MFDS oversight and a similar two-tier claim system to Japan.

None of this tells you whether a specific product works or is safe for you personally. It tells you how much independent government review, if any, stood between the manufacturer’s claims and the store shelf. For a broader look at how to evaluate sourcing quality once a product is legally on the market, see our guide on fruiting body versus mycelium sourcing.

What Labels and Testing Certificates Can (and Can’t) Prove

Regulatory status is not the same thing as product testing. A supplement can be perfectly legal to sell in the US without any third-party lab having ever verified what’s actually in the bottle.

• A Certificate of Analysis (COA), when provided by a company, generally reflects a single tested batch, identified by a lot number and a test date. It does not automatically apply to every bottle a company has ever sold or will sell.
• Third-party certification marks (from organizations that test finished products) mean something different than a company’s own internal quality claims. Check whether the certifying body is named, whether the certificate is dated, and whether it is specific to that product.
• A country with a formal approval pathway, such as the EU’s novel food system, does not mean every product from that region has gone through it. Unauthorized products can still end up for sale, especially online.
• We do not test products ourselves. When we discuss testing or certification in our reviews, we report only what a company has published or provided and note when no dated test documentation is available.

If you want to know what a specific product’s testing actually covers, look for a dated COA tied to that product’s lot number, not a general claim of “lab tested” on the packaging. Our guide to supplement formats also covers how format affects what’s practical to standardize and test.

Groups Who Should Use Extra Caution

Regulatory approval, where it exists, is about ingredient-level safety review. It is not personalized medical advice. Talk with a healthcare provider before starting a mushroom supplement if you are:

• Pregnant or breastfeeding
• Taking prescription medication, especially blood thinners, immunosuppressants, or diabetes medication
• Living with a liver or kidney condition
• Scheduled for surgery in the near future
• Considering giving a supplement to a child

Frequently Asked Questions

Does “FDA registered” mean a supplement was approved as safe?

No. The FDA does not approve dietary supplements before they go to market. Some companies register their manufacturing facility with the FDA, which is a facility-level requirement, not a product safety approval. If a label implies FDA approval of the product itself, treat that as a red flag.

Why can the same mushroom ingredient be legal in the US but restricted in the EU?

The US and EU use fundamentally different systems. The US lets companies market supplements without pre-approval and enforces rules after the fact. The EU requires many mushroom extracts to pass a formal novel food safety review before sale, and that review happens extract by extract, not for the mushroom species as a whole.

Do Asian regulatory approvals, such as China’s health food system, apply outside that country?

No. A health food filing or registration in China, an FOSHU or FFC designation in Japan, or a Health Functional Food Act approval in Korea applies only within that country’s market. A product legally sold in one of these markets is not automatically authorized for sale elsewhere.

Is a supplement safer just because it comes from a country with stricter pre-market review?

Not necessarily. Stricter pre-market review reduces certain risks, such as unauthorized novel ingredients entering the EU market. It doesn’t commitment an individual product is well-made, accurately labeled, or right for your personal health situation. Manufacturing quality and honest labeling still vary within any regulatory system.

Evidence Limits

Regulatory frameworks change, and this article reflects a general description of current systems rather than a complete legal reference. Rules, authorized ingredient lists, and agency procedures are updated over time by each government. If you are making a business, import, or purchasing decision that depends on current legal status, verify directly with the relevant agency (the FDA in the US, EFSA and the European Commission in the EU, or the SAMR, MHLW/Consumer Affairs Agency, or MFDS in China, Japan, and Korea, respectively) rather than relying on this summary alone.

This article is for educational purposes only and does not constitute medical, legal, or regulatory advice. Always consult a qualified healthcare provider before starting any supplement, and verify current import and sale requirements directly with the relevant government agency before making business decisions based on this information.